ArticleCancer chemotherapy and pharmacology2024

Assessing pharmacokinetics and drug-drug interactions of the combination therapy of myelofibrosis with ruxolitinib and lenalidomide by a new eco-friendly HPLC method for their simultaneous determination in plasma.

Rashed N Herqash et al.PubMed ↗Publisher ↗

No numbers read from the abstract.